Volver a Agendas
Session Chair(s)
Fumiaki Kobayashi, PhD
President
CTD inc., Japan
Speaker(s)
Current Status of Pediatric Drug Development: Pharmaceutical Industry Viewpoints
Takeshi Nakanishi
GlaxoSmithKline K.K., Japan
Department Manager, New Drug RA Department, Regulatory Affairs
Development of Pediatric Drugs in Japan: Regulatory Viewpoints
Mayumi Iwata-Okada, MD, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Principle Reviewer, Office of Vaccines and Blood Products
How Can We Facilitate the Drug Development in Children? View from the Academia.
Hidefumi Nakamura, MD, PhD
National Center for Child Health and Development, Japan
Director for Clinical R&D,
¿Tiene una cuenta?